Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camila Masias

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Blood|July 27, 2023
The impact of TTP in the brainCamila Masias
British Journal of Haematology|June 16, 2026
The quiet brain injury in thrombotic thrombocytopenic purpura: Are we missing the warning signs?Camila Masias
Hematology. American Society of Hematology. Education Program|December 9, 2023
Should older patients with low weight and CKD receive full-dose DOACs for treatment of acute proximal DVT?Nicolas Gallastegui, Camila Masias
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Novel therapies in thrombotic thrombocytopenic purpuraCamila Masias, Spero R Cataland
Blood|July 15, 2018
The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosisCamila Masias, Spero R Cataland
Blood|June 21, 2019
How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknownsMarshall A Mazepa, Camila Masias, Shruti Chaturvedi
Blood|April 19, 2017
None of the above: thrombotic microangiopathy beyond TTP and HUSCamila Masias, Sumithira Vasu, Spero R Cataland
Laboratory Medicine|April 5, 2024
When you think you should transfuse…don't!Richard R Gammon, Harold Alvarez, Camila Masias, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2023
Five years of caplacizumab - lessons learned and remaining controversies in immune-mediated thrombotic thrombocytopenic purpuraLinus Alexander Völker, Paul Thomas Brinkkoetter, Spero R Cataland, et al.
Research and Practice in Thrombosis and Haemostasis|October 31, 2025
Plasminogen mutation-associated thrombotic microangiopathy and role of anticoagulation: a single institution case seriesShreya Agarwal, Nicola Pozzi, Senthil Sukumar, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Blood|July 27, 2023
The impact of TTP in the brainCamila Masias
British Journal of Haematology|June 16, 2026
The quiet brain injury in thrombotic thrombocytopenic purpura: Are we missing the warning signs?Camila Masias
Hematology. American Society of Hematology. Education Program|December 9, 2023
Should older patients with low weight and CKD receive full-dose DOACs for treatment of acute proximal DVT?Nicolas Gallastegui, Camila Masias
Research and Practice in Thrombosis and Haemostasis|July 27, 2018
Novel therapies in thrombotic thrombocytopenic purpuraCamila Masias, Spero R Cataland
Blood|July 15, 2018
The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosisCamila Masias, Spero R Cataland
Blood|June 21, 2019
How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknownsMarshall A Mazepa, Camila Masias, Shruti Chaturvedi
Blood|April 19, 2017
None of the above: thrombotic microangiopathy beyond TTP and HUSCamila Masias, Sumithira Vasu, Spero R Cataland
Laboratory Medicine|April 5, 2024
When you think you should transfuse…don't!Richard R Gammon, Harold Alvarez, Camila Masias, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2023
Five years of caplacizumab - lessons learned and remaining controversies in immune-mediated thrombotic thrombocytopenic purpuraLinus Alexander Völker, Paul Thomas Brinkkoetter, Spero R Cataland, et al.
Research and Practice in Thrombosis and Haemostasis|October 31, 2025
Plasminogen mutation-associated thrombotic microangiopathy and role of anticoagulation: a single institution case seriesShreya Agarwal, Nicola Pozzi, Senthil Sukumar, et al.
Pageof 3